Collagen-binding proteoglycan fibromodulin can determine stroma matrix structure and fluid balance in experimental carcinoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 104, Issue 35, 2007, Pages 13966-13971

  Oldberg, Åke ^a   Kalamajski, Sebastian ^a   Salnikov, Alexei V ^c,d,g   Stuhr, Linda ^e   Mörgelin, Matthias ^b   Reed, Rolf K ^e   Heldin, Nils Erik ^f   Rubin, Kristofer ^c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF BERGEN   (Norway)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Inflammation; Interstitial fluid pressure; Physiology; TGF ; Tumor physiology

Indexed keywords

ANTIINFLAMMATORY AGENT; COLLAGEN; FIBROMODULIN; PROTEOGLYCAN; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD; CANCER MODEL; CARCINOMA; CONNECTIVE TISSUE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; FLUID BALANCE; GENE EXPRESSION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; THERMODYNAMICS; TISSUE PRESSURE; ANIMAL; C57BL MOUSE; EXTRACELLULAR FLUID; GENETICS; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; THYROID TUMOR; ULTRASTRUCTURE; VASCULARIZATION;

ANIMALS; CARCINOMA; COLLAGEN; EXTRACELLULAR FLUID; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROTEOGLYCANS; THYROID NEOPLASMS;

EID: 35348839617     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0702014104     Document Type: Article

References (41)

1. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK, McDonald DM (2000) Am J Pathol 156:1363-1380.
2. Mueller MM, Fusenig NE (2004) Nat Rev Cancer 4:839-849.
3. Bhowmick NA, Neilson EG, Moses HL (2004) Nature 432:332-337.
4. Liotta LA, Kohn EC (2001) Nature 411:375-379.
5. Hanahan D, Weinberg RA (2000) Cell 100:57-70.
6. Coussens LM, Werb Z (2002) Nature 420:860-867.
7. Dvorak HF (1986) N Engl J Med 315:1650-1659.
8. Anderson AR, Weaver AM, Cummings PT, Quaranta V (2006) Cell 127:905-915.
9. Jain RK (1987) Cancer Res 47:3039-3051.
10. Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK (2000) Cancer Res 60:2497-2503.
11. Heldin C-H, Rubin K, Pietras K, Östman A (2004) Nat Rev Cancer 4:806-813.
12. Emerich DF, Dean RL, Snodgrass P, Lafreniere D, Agostino M, Wiens T, Xiong H, Hasler B, Marsh J, Pink M, et al. (2001) J Pharmacol Exp Ther 296:632-641.
13. Pietras K, Rubin K, Sjöblom T, Buchdunger E, Sjöquist M, Heldin C-H, Östman A (2002) Cancer Res 62:5476-5484.
14. Salnikov AV, Iversen VV, Koisti M, Sundberg C, Johansson L, Stuhr LB, Sjöquist M, Ahlström H, Reed RK, Rubin K (2003) FASEB J 17:1756-1758.
15. Willett CG, Boucher Y, Di Tomaso E, Duda DG, Munn LL, Tong RT, Chung DC, Sahani DV, Kalva SP, Kozin SV, et al. (2004) Nat Med 10:145-147.
16. Lammerts E, Roswall P, Sundberg C, Gotwals PJ, Koteliansky VE, Reed RK, Heldin N-E, Rubin K (2002) Int J Cancer 102:453-462.
17. Salnikov AV, Roswall P, Sundberg C, Gardner H, Heldin N-E, Rubin K (2005) Lab Invest 85:512-521.
18. Lee CG, Heijn M, di Tomaso E, Griffon-Etienne G, Ancukiewicz M, Koike C, Park KR, Ferrara N, Jain RK, Suit HD, Boucher Y (2000) Cancer Res 60:5565-5570.
19. Salnikov AV, Heldin N-E, Stuhr LB, Wiig H, Gerber H, Reed RK, Rubin K (2006) Int J Cancer 119:2795-2802.
20. Ameye L, Young MF (2002) Glycobiology 12:107R-116R.
21. Heinegård D, Larsson T, Sommarin Y, Franzén A, Paulsson M, Hedbom E (1986) J Biol Chem 261:13866-13872.
22. Saamanen AM, Salminen HJ, Rantakokko AJ, Heinegård D, Vuorio E (2001) Biochem J 355:577-585.
23. Svensson L, Aszodi A, Reinholt FP, Fässler R, Heinegård D, Oldberg Å (1999) J Biol Chem 274:9636-9647.
24. Gill MR, Oldberg Å, Reinholt FP (2002) Osteoarthritis Cartilage 10:751-757.
25. Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, Oldberg A, Birk DE, Chakravarti S (2002) J Biol Chem 277:35532-35540.
26. Ameye L, Aria D, Jepsen K, Oldberg Å, Xu T, Young MF (2002) FASEB J 16:673-680.
27. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al. (2002) Nature 415:530-536.
28. Welsh JB, Sapinoso LM, Su AI, Kern SG, Wang-Rodriguez J, Moskaluk CA, Frierson HF, Jr, Hampton GM (2001) Cancer Res 61:5974-5978.
29. Garber ME, Troyanskaya OG, Schluens K, Petersen S, Thaesler Z, Pacyna-Gengelbach M, van de Rijn M, Rosen GD, Perou CM, Whyte RI, et al. (2001) Proc Natl Acad Sci USA 98:13784-13789.
30. Ueno H, Jones AM, Wilkinson KH, Jass JR, Talbot IC (2004) Gut 53:581-586.
31. Sis B, Sarioglu S, Sokmen S, Sakar M, Kupelioglu A, Fuzun M (2005) J Clin Pathol 58:32-38.
32. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ (2003) Cell 114:33-45.
33. Geng Y, McQuillan D, Roughley PJ (2006) Matrix Biol 25:484-491.
34. Murdoch C, Muthana M, Lewis CE (2005) J Immunol 175:6257-6263.
35. Gordon S (2003) Nat Rev Immunol 3:23-35.
36. Kristjansen PE, Boucher Y, Jain RK (1993) Cancer Res 53:4764-4766.
37. Levick JR (1987) Q J Exp Physiol 72:409-437.
38. Znati CA, Rosenstein M, McKee TD, Brown E, Turner D, Bloomer WD, Watkins S, Jain RK, Boucher Y (2003) Clin Cancer Res 9:5508-5513.
39. Brown E, McKee T, diTomaso E, Pluen A, Seed B, Boucher Y, Jain RK (2003) Nat Med 9:796-800.
40. Berg RA (1982) Methods Enzymol 82:372-398.
41. Ohtani O, Ushiki T, Taguchi T, Kikuta A (1988) Arch Histol Cytol 51:249-261.